Does trazodone cause weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Trazodone Cause Weight Gain?

Trazodone is weight-neutral and does not cause clinically significant weight gain; in fact, it may produce slight weight loss in overweight patients, making it one of the safer antidepressant options when weight concerns are present. 1, 2, 3

Evidence from FDA Labeling and Clinical Trials

  • The FDA label for trazodone reports weight gain occurring in only 1-5% of patients in controlled trials, with weight loss actually occurring at similar or higher rates (3-6%), indicating overall weight neutrality 1

  • A direct comparison trial of 272 depressed patients found that trazodone produced slight weight loss in overweight patients, while amitriptyline (a tricyclic antidepressant) caused significant weight gain 3

  • In a 6-week comparative trial, trazodone-treated patients experienced a mean weight gain of only 1.2 lbs, compared to bupropion which caused a 2.5 lb weight loss 4

Comparative Context Among Antidepressants

When considering antidepressants and weight effects, trazodone ranks among the most weight-favorable options available:

  • Weight-neutral options: Trazodone, fluoxetine, sertraline, and most benzodiazepines/hypnotics 2, 5

  • Weight-loss promoting: Bupropion is the only antidepressant consistently associated with weight loss through appetite suppression 5

  • High weight gain risk (avoid these): Paroxetine (highest among SSRIs), mirtazapine, amitriptyline (highest among tricyclics), and MAO inhibitors 5, 3

Clinical Decision Algorithm for Antidepressant Selection

If weight is a primary concern:

  1. First choice: Bupropion (if no contraindications such as seizure disorders or eating disorders exist) 5

  2. Second-line choices: Trazodone, fluoxetine, or sertraline for their weight-neutral profiles 5, 2

  3. Avoid entirely: Paroxetine, mirtazapine, amitriptyline, and MAO inhibitors 5

Mechanism and Clinical Implications

  • Trazodone's weight neutrality distinguishes it from many other psychotropic medications that antagonize serotonin receptors and stimulate carbohydrate craving 6

  • The low incidence of weight gain, combined with minimal sexual dysfunction, may improve long-term adherence to treatment 7

  • Recent evidence confirms trazodone maintains its weight-neutral profile even with the once-daily formulation at therapeutic doses of 150-300 mg/day 7

Important Clinical Caveats

  • While trazodone is weight-neutral, individual variations can occur; regular weight monitoring remains appropriate during any antidepressant treatment 2

  • Trazodone's most common adverse effects are somnolence, headache, dizziness, and dry mouth—not metabolic effects 7

  • The appetite increase reported with trazodone in FDA labeling occurred at rates similar to placebo, further supporting its weight-neutral classification 1

References

Research

Comparison of bupropion and trazodone for the treatment of major depression.

Journal of clinical psychopharmacology, 1994

Guideline

Antidepressant-Associated Weight Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Induction of obesity by psychotropic drugs.

Annals of the New York Academy of Sciences, 1987

Related Questions

What anti-anxiety medication can also aid in weight loss?
What is the effect of a 450mg dose of trazodone?
In a 9‑year‑old child with behavioral issues, which mood stabilizer is least likely to cause weight gain?
What is the best management approach for a patient with MDD, anxiety, and ADHD, currently on Lexapro (escitalopram), Vyvanse (lisdexamfetamine), and Trazodone (trazodone)?
In a 42-year-old male smoker taking Vyvanse (lisdexamfetamine) for ADHD who has unintentionally lost 6 pounds over two months, should this weight loss be concerning?
How should I manage a patient with stage 3a chronic kidney disease (eGFR 64 mL/min/1.73 m²), low vitamin B12 (88 pg/mL), low folate (1.0 ng/mL), low‑normal calcium (8.8 mg/dL), mildly suppressed thyroid‑stimulating hormone (0.44 µIU/mL) and otherwise normal laboratory values?
What is the clinical significance of elevated haptoglobin (221 mg/dL), high apolipoprotein A‑1 (192 mg/dL), normal total bilirubin, mildly increased γ‑glutamyl transferase (60 U/L) and alanine aminotransferase (57 U/L)?
What are the diagnostic criteria for metabolic syndrome and how should it be managed, including lifestyle modification and pharmacologic therapy?
In women older than 65 years, when is iron supplementation indicated and what is the recommended dosing, duration, and monitoring strategy?
Can a recent parainfluenza infection trigger autoimmune conditions such as Guillain‑Barré syndrome, acute disseminated encephalomyelitis, or arthritis, and how should they be managed?
What is the recommended acetaminophen (Tylenol) dose for adults and children, and how should it be adjusted for weight, liver disease, or alcohol use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.